Osimertinib and Palbociclib in an EGFR-mutated NSCLC with Primary CDK4 Amplification after Progression under OsimertinibVincent D. de Jager,Jos A. Stigt,Maarten Niemantsverdriet,Arja ter Elst,Anthonie J. van der WekkenNPJ PRECISION ONCOLOGY（2024）引用 2|浏览15AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
